Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis

scientific article published on 01 November 2006

Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.CAD.0000236309.66080.3B
P698PubMed publication ID17075321

P50authorBruno CoudertQ51368266
P2093author name stringMichel Flesch
Bruno Chauffert
Pierre Fumoleau
Nicolas Isambert
Jean-Claude Guilland
Bernard Royer
Pierre Fargeot
Sylvie Zanetta
Jean Fraisse
Laurent Benoit
Françoise Mayer
Cécile Molucon-Chabrot
Pascale Monin-Baroille
P433issue10
P921main subjectperitoneal carcinomatosisQ2071182
epinephrineQ28163586
P304page(s)1211-1217
P577publication date2006-11-01
P1433published inAnti-Cancer DrugsQ4774128
P1476titleFeasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis
P478volume17

Reverse relations

cites work (P2860)
Q34510371Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis
Q35739551Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study
Q41132998Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer
Q33416610Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy
Q83393453[Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis]

Search more.